EP3481415

LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP17742825A
Filing Date
Jul 6, 2017
Status
Granted And Under Opposition
Aug 4, 2023
Grant Date
Sep 6, 2023
External Links
Slate, Register

Biblio Summary

The patent EP3481415B1 was granted on Sep 6, 2023 by Laboratoire Français Du Fractionnement Et Des Biotechnologies The patent is currently Granted And Under Opposition.

The table below shows 3 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOTEST AGJun 5, 2024ADMISSIBLE
TAKEDA PHARMACEUTICALS INTERNATIONAL AGJun 5, 2024ADMISSIBLE
MARCHANT, MICHAELMay 24, 2024ADMISSIBLE

The table below shows the patents of Laboratoire Français Du Fractionnement Et Des Biotechnologies that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3806891Combination Of Factor Vii And An Anti-Factor Ix/X Bispecific AntibodyAug 2, 20231
EP2651978Use Of An Antibody Directed Against A Membrane ProteinJan 12, 20221
EP3390452New Use Of An Anti-Cd303 Transmembrane Protein AntibodyMay 26, 20211